ANAVEX LIFE SCIENCES CORP.
Developing precision therapeutics for neurodegenerative and CNS disorders.
AVXL | NDAQ
Overview
Corporate Details
- ISIN(s):
- US0327973006
- LEI:
- Country:
- United States of America
- Address:
- 630 5TH AVENUE, 10111 NEW YORK
- Website:
- https://www.anavex.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted therapeutics for central nervous system (CNS) disorders. The company applies a precision medicine approach, utilizing genomic biomarkers to develop treatments for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and other neurological conditions. Its pipeline features orally available drug candidates designed to restore cellular homeostasis by targeting key receptors like SIGMAR1 and muscarinic receptors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ANAVEX LIFE SCIENCES CORP. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ANAVEX LIFE SCIENCES CORP.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ANAVEX LIFE SCIENCES CORP. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
